Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: A multicenter randomized controlled trial with a 1-year open extension followup

Arthritis Care and Research

Volumn 65, Issue 12, 2013, Pages 1959-1968

  Alemo Munters, Li ^a   Dastmalchi, Maryam ^b   Andgren, Vivianne ^c   Emilson, Christina ^d   Bergegård, Jenny ^b   Regardt, Malin ^a   Johansson, Anna ^c   Orefelt Tholander, Ingrid ^d   Hanna, Balsam ^c   Lidén, Maria ^d   Esbjörnsson, Mona ^a   Alexanderson, Helene ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DERMATOMYOSITIS; DISABILITY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROCARDIOGRAPHY; ENDURANCE TRAINING; FEMALE; FOLLOW UP; HUMAN; MALE; MCMASTER TORONTO ARTHRITIS PATIENT PREFERENCE DISABILITY QUESTIONNAIRE; MULTICENTER STUDY; MUSCLE FUNCTION; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PHYSICAL PERFORMANCE; POLYMYOSITIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; VENOUS OXYGEN TENSION;

ACTIVITIES OF DAILY LIVING; DERMATOMYOSITIS; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; PATIENT PREFERENCE; PHYSICAL ENDURANCE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84888988753     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22068     Document Type: Article

References (50)

1. Hengstman GJ, van den Hoogen FH, van Engelen BG,. Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother 2009; 10: 1183-90.
2. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 2009; 48: 134-9.
3. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-7.
4. Sultan SM, Ioannou Y, Moss K, Isenberg DA,. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002; 41: 22-6.
5. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K,. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) 2005; 44: 83-8.
6. Bronner IM, van der Meulen MF, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65: 1456-61.
7. Regardt M, Welin Henriksson E, Alexanderson H, Lundberg IE,. Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology (Oxford) 2011; 50: 578-85.
8. Zong M, Lundberg IE,. Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol 2011; 7: 297-306.
9. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT,. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 1994; 330: 1549-54.
10. Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81: 1-5.
11. Alexanderson H, Lundberg IE,. Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol 2012; 24: 201-7.
12. Habers GE, Takken T,. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy: a systematic review. Rheumatology (Oxford) 2011; 50: 2113-24.
13. Nader GA, Lundberg IE,. Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 2009; 21: 599-603.
14. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA,. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11: 607-15.
15. Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE,. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007; 57: 768-77.
16. Nader GA, Dastmalchi M, Alexanderson H, Grundtman C, Gernapudi R, Esbjornsson M, et al. A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med 2010; 16: 455-64.
17. Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998; 37: 196-200.
18. Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/ dermatomyositis patients. Br J Rheumatol 1998; 37: 1338-42.
19. Bohan A, Peter JB,. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
20. Bohan A, Peter JB,. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
21. Sullivan M, Karlsson J, Ware JE Jr,. The Swedish SF-36 health survey. I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 1349-58.
22. Alemo Munters L, van Vollenhoven RF, Alexanderson H,. Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. ISRN Rheumatol 2011; 2011: 463124.
23. Verhoeven AC, Boers M, van der Liden S,. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000; 27: 2801-9.
24. Alexanderson H, Lundberg IE, Stenstrom CH,. Development of the Myositis Activities Profile: validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 2002; 29: 2386-92.
25. Borg GA,. Perceived exertion. Exerc Sport Sci Rev 1974; 2: 131-53.
26. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004; 43: 49-54.
27. Sultan SM, Allen E, Cooper RG, Agarwal S, Kiely P, Oddis CV, et al. Interrater reliability and aspects of validity of the myositis damage index. Ann Rheum Dis 2011; 70: 1272-6.
28. Weiss RE,. Modeling longitudinal data. New York: Springer; 2005.
29. Munro B,. Statistical methods for health care research. 3rd ed. Philadelphia: JB Lippincott; 1997.
30. Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990; 33: 477-84.
31. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, et al, for the International Myositis Assessment and Clinical Studies Group. International Consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50: 2281-90.
32. Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, et al. Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 2007; 23: 731-9.
33. Alexanderson H, Stenstrom CH, Lundberg I,. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999; 38: 608-11.
34. Penedo FJ, Dahn JR,. Exercise and well-being: a review of mental and physical health benefits associated with physical activity. Curr Opin Psychiatry 2005; 18: 189-93.
35. Neill J, Belan I, Ried K,. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 2006; 56: 617-35.
36. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE,. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793-801.
37. Sokka T, Hakkinen A,. Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases. Clin Exp Rheumatol 2008; 26 Suppl: S14-20.
38. Warburton DE, Nicol CW, Bredin SS,. Health benefits of physical activity: the evidence. CMAJ 2006; 174: 801-9.
39. Walsh NP, Gleeson M, Shephard RJ, Woods JA, Bishop NC, Fleshner M, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011; 17: 6-63.
40. Sloan RP, Shapiro PA, Demeersman RE, McKinley PS, Tracey KJ, Slavov I, et al. Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 2007; 103: 1007-11.
41. Petersen AM, Pedersen BK,. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-62.
42. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003; 42: 861-8.
43. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF,. Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans. FASEB J 2001; 15: 475-82.
44. Tracey KJ,. Reflex control of immunity. Nat Rev Immunol 2009; 9: 418-28.
45. De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003; 48: 2415-24.
46. Verhoeven AC, Boers M, van der Linden S,. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Ann Rheum Dis 2000; 59: 966-74.
47. Nguyen C, Mouthon L, Mestre-Stanislas C, Rannou F, Berezne A, Sanchez K, et al. Sensitivity to change in systemic sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): shift in patient priorities over time. J Rheumatol 2010; 37: 359-64.
48. Bogdanis GC,. Effects of physical activity and inactivity on muscle fatigue. Front Physiol 2012; 142: 1-15.
49. Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI,. Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care 2012; 35: 2681-9.
50. Boutron I, Moher D, Altman DG, Schultz KF, Ravaud P,. Methods. and processes of the CONSORT group: example of an extension of trials assessing nonpharmacologic treatments. Ann Intern Med 2008; 148: 60-6.